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ABSTRACT
Objective: To examine patient and primary healthcare
factors and stage at diagnosis in women with cervical
cancer in Northern Uganda with the intention to
identify factors that are associated with advanced
stages in order to inform policies to improve survival
from cervical cancer in low income and middle income
countries.
Design: Cross-sectional hospital-based study.
Setting: Tertiary, not-for-profit private hospital in
postconflict region.
Participants: Consecutive tissue-diagnosed
symptomatic patients with cervical attending care. Of
166 patients, 149 were enrolled and analysed.
Primary outcome: Cervical cancer stage at diagnosis.
Results: Most women were diagnosed at stages III
(45%) or IV (21%). After controlling for age, marital
status, educational attainment and number of biological
children, there was evidence for association between
advanced stage at diagnosis and pre-referral diagnosis
of cancer by primary healthcare professionals (adjusted
OR (AOR)=13.04:95% CI 3.59 to 47.3), and financial
difficulties precluding prompt help seeking
(AOR=5.5:95% CI 1.58 to 20.64). After adjusting for
age, marital status and educational attainment, women
with 5–9 biological children (AOR=0.27:95% CI 0.08 to
0.96) were less likely to be diagnosed with advanced
stage (defined as stages III/IV) cancer. In this pilot
study, there was no statistical evidence for associations
between stage at diagnosis, and factors such as age at
diagnosis and marital status.
Conclusions: This study is a first attempt to
understand the descriptive epidemiology of cervical
cancer in rural Ugandan settings. Understanding
individual patient factors, patients’ behavioural
characteristics and healthcare factors associated with
advanced stage at diagnosis is essential for targeted
effective public health interventions to promote prompt
health seeking, diagnosis at early stage and improved
survival from cervical cancer.
BACKGROUND
In Uganda and most low income and middle
income countries (LMICs), there is limited
evidence about the distribution of stage at
diagnosis of cervical cancer, and about
factors that contribute to advanced stage at
diagnosis. In Nepal, up to 81% of patients
with cervical cancer are diagnosed with
advanced stage cancer. Women who were
more likely to be diagnosed with advanced
stage cancer included those who did not dis-
close their symptoms to signiﬁcant others
promptly (adjusted OR (AOR)=4.27) and
those who disclosed symptoms to relations
other than their husbands (AOR=12.70).1
Strengths and limitations of this study
▪ This is a pioneering study in a low income
country to apply the theoretical framework—the
Model of Pathways to Treatment—to evaluate
factors that may influence symptom appraisal
and help-seeking intervals for symptomatic
patients with cervical cancer.
▪ Participants were prospectively recruited thereby
minimising methodological concerns associated
with retrospective studies.
▪ Diagnosis of cervical cancer was confirmed by
tissue histology and following examinations
under anaesthesia, thus obviating possibilities of
diagnostic misclassifications.
▪ Potential recall or social desirability biases are
inherent in patient interview studies. Most
patients presented long after onset of symptoms
and could have had difficulty in recall of some
events.
▪ This was a hospital-based study involving a
selected population of women who had reached
the hospital. The characteristics of women who
may have cervical cancer but who have not
reached the study hospital remain unknown.
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A modiﬁable predictor of treatment outcome is time
to diagnosis of symptomatic cervical cancer. Among
symptomatically detected women with cervical cancer in
Sweden, those with shorter symptom durations had 14%
higher chances of cure compared to those with longer
symptom duration.2 However, in most LMICs, the diag-
nostic journeys of most women with cervical cancer
symptoms are dominated by long patient and primary
care intervals. Of 110 symptomatic patients with cervical
cancer in Nepal, the median total time to diagnosis
(diagnostic interval) was 157 days while the median
patient and healthcare provider intervals were 68.5 days
and 40 days, respectively. Fifty-seven per cent of the
patients had experienced longer patient intervals of
>2 months.3 Diagnosing cervical cancer at an early stage
requires that women recognise and appraise the import-
ance of possible cervical cancer symptoms early and
seek care promptly.4 Nonetheless, even when women
seek care for cervical cancer symptoms, diagnosis may
be delayed because primary healthcare professionals
face challenges in promptly recognising symptoms and
referring patients with possible cervical cancer.5 6 In
Uganda, data from the Kampala Cancer Registry (which
serves a population in close proximity to specialised
cancer treatment centres) suggest that women in central
Uganda present with advanced stage cervical cancer and
have poor prognosis.7 8 Previous studies, however, have
not been able to examine factors that are likely to inﬂu-
ence the promptness of diagnosis; such factors might
vary within and between countries and regions.
Understanding of context-speciﬁc factors including
patient-related and primary healthcare-related factors
that lead to delay in a particular country can guide
development of targeted interventions and policies to
increase prompt appraisal of cervical cancer symptoms,
and enable timely help seeking.
In spite of cervical cancer being a very common
cancer, responsible for 2275 deaths every year (27.2
deaths per 100 000 women), women with cervical cancer
in Uganda are an understudied population.9 Against this
background, we set out to examine patient and primary
healthcare factors, and stage at diagnosis in women with
cervical cancer in Northern Uganda, with the intention
of establishing the feasibility of future larger studies
aimed at identifying factors associated with advanced
stages in broader populations.
METHODS
Theoretical framework
The data collection and analysis in this study were
underpinned by the Model of Pathways to Treatment
(MPT).10 11 In this model (ﬁgure 1), the cancer journey
from symptom recognition through help seeking, diag-
nosis and treatment, is viewed as an iterative process
composed of events and processes with distinguishable
intervals. These events and associated intervals are inﬂu-
enced by factors such as patient demographics, health-
care access and disease factors, including rate of
progressions and histological subtypes. In using the
MPT, researchers and policymakers can gain insight into
actual points along the journey where delay may occur
and hence provide opportunities for design of targeted
interventions.11
The operational deﬁnitions for different measures
and markers of promptness of diagnosis used in this
Figure 1 Model of Pathways to Treatment. HCP, healthcare professional.
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study are presented in table 1. These deﬁnitions were
informed by the MPT model, and an international con-
sensus statement on the measurement of different diag-
nostic intervals12 and evidence indicating that the
number of pre-referral consultations is a valid marker of
the primary care interval.13
Design and setting
We carried out a cross-sectional survey of patients with
cervical cancer attending St Mary’s Hospital Lacor—a
tertiary 400-bed not-for-proﬁt hospital in northern
Uganda. This was a pragmatic feasibility study to
increase knowledge and help pave the way for the
conduct of larger multisite studies.
Participants and recruitment
We consecutively recruited all women with cervical
cancer diagnosed and treated in the gynaecology depart-
ment over the study period of 1½ years. In all women,
the diagnosis was conﬁrmed with tissue histology and
stage was assigned based on the ﬁndings of examination
under anaesthesia (EUA), carried out by a gynaecolo-
gist. Staging was performed according to the
International Federation of Gynaecology and Obstetrics
(FIGO) staging criteria.14 Sampling was conﬁned to
women diagnosed within a maximum period of
6 months from the date of recruitment.
Screening-detected women were a priori excluded.
Patients who could not be interviewed because of lan-
guage problems were also excluded. Altogether, 17 of
166 women seen in the hospital during the study period
were excluded; ﬁve were diagnosed more than 6 months
before study recruitment, two declined to participate
because they wanted to go immediately for radiotherapy
in the capital city, Kampala, four unexpectedly left hos-
pital soon after EUAs and ﬁve were too sick to be
interviewed. An 18-year-old patient with EUA report
showing a fungating mucinous cervical mass was
excluded because histopathology revealed diagnosis of
sarcoma botryoides. The sample therefore included 149
women.
Data collection
Data were collected from the patients, using structured
interviews based on a questionnaire administered by a
research assistant. We designed the questionnaire based
on contributing factors, events and intervals in the
Model of Pathways to Treatment, ﬁndings from studies
on cervical cancer in sub-Saharan Africa and our own
clinical experiences.11 15 The questionnaire had three
sections: sociodemographic characteristics; knowledge
and beliefs about cervical cancer including awareness of
risk factors, symptoms and beliefs about treatment and
cure; and information about care processes including
symptoms appraisal, duration and help-seeking behav-
iour. The questionnaire also included open-ended ques-
tions about symptoms, the distance from home to
nearest health unit and to the study hospital, and the
number of times health units were visited before coming
to the study hospital. Responses from the open-ended
questions were reviewed and aggregated before further
analysis. Symptoms that were reported by fewer than ﬁve
participants were categorised as ‘other’ and excluded
from the main analyses.
The study tool was double translated by two independ-
ent translators ﬂuent in English and Luo/Acholi, the
main local language spoken in the study area. A third
translator reviewed both Luo versions and harmonised
them to form the ﬁnal tool used in data collection.
A female registered nurse with additional and midwif-
ery qualiﬁcation was trained as research assistant for this
study. The research assistant was trained for 2 days on
Table 1 Operational definitions
Term/concept Definition Author
Date of first symptom The date or estimated time in the week, month or year when the patient first felt a
bodily change requiring discussion with a healthcare professional and/or with
another person with the intention of gaining understanding of the symptoms and/
or how to deal with them
Weller D, et al12
Patient interval The time period from detection of abnormal bodily sensations to time of visiting
first healthcare professional to discuss the symptoms including the period from
lower level units to the study hospital for diagnosis of cancer
Weller D, et al12
Date of first
presentation
The time point in the week, month or year including a particular date when the
patient first visited a healthcare professional in a private or public health facility to
discuss the symptoms that she had and that have since been attributed to
cervical cancer at the study hospital
Weller D, et al12
Date of diagnosis Date when examination under anaesthesia for clinical diagnosis and staging was
performed.
Weller D, et al12
Pre-referral
consultations
Any visits to a healthcare professional in an established healthcare setting
including lower level healthcare facilities and private clinics before presentation to
and diagnosis at the study hospital
Lyratzopoulos G,
et al13
Pre-referral suspicion
or diagnosis of cancer
Any reports by participants referring to being told of a cancer diagnosis by
primary healthcare professionals before referral to study hospital
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basic facts on cervical cancer and the study procedures
including criteria for inclusion, consent procedures and
data collection. The research assistant introduced the
study to prospective participants after the patients were
informed of their cancer diagnoses by the attending
physicians as part of their standard care. After at least
5 days from the disclosure of cancer diagnoses, the
research assistant administered the questionnaire, mostly
in the local language. The research assistant read out
the questions and coded responses to the participants,
and ticked and/or recorded responses accordingly.
However, for the questions concerning risk factors and
perceived causes, the research assistant did not prompt
recall by reading out the options but ticked all coded
responses as the participants mentioned them. She
prompted participants to mention as many risk factors/
perceived causes as possible by asking, “what else do you
think may also cause this cancer?” This was performed
to avoid suggesting risk factors that participants would
not have thought about. Administration of question-
naires lasted about 45–60 min. The research assistant
abstracted clinical data such as cancer stage and hist-
ology from the patients’ case notes and histopathology
laboratory record. Recruitment and data collection were
conducted from September 2012 to April 2014.
Data analysis
Data entry was performed by two independent clerks
using Epidata V.3.1 software and analysis carried out
using STATA I/C V.12.0. The outcome measure was
cancer stage at diagnosis, dichotomised as early (I/II) or
advanced stage (III/IV). Independent variables/covari-
ates included sociodemographic characteristics, time to
diagnosis, estimated road distance from study hospital,
initial symptom attributions, pre-referral diagnoses by
primary healthcare professionals, number of pre-referral
visits, health-seeking intervals and reported reasons for
non-prompt health seeking. Bivariate and multivariable
logistic regressions were used to determine associations.
For multivariable regression analysis, variables were
included based on biological plausibility rather than a
predetermined p value in bivariate analyses. Odd ratios
and accompanying 95% CIs are reported.
Ethical clearance
Participants were informed of study objectives, consent
procedures and potential beneﬁts and harms, and their
right to decline participation and/or withdraw at any
time without fear of retribution or compromise to their
cancer management plans. All participants provided
informed individual consents with a signature or thumb
print.
RESULTS
Characteristics of participants
One hundred forty-nine women with cervical cancer
were included in the analysis. The mean age (±SD) was
48±13 years. Fifty-seven per cent of participants were
married; 45% reported no formal education and 89%
were not formally employed. Seventy-two per cent of par-
ticipants had ﬁve children or more while 39% of partici-
pants lived more than 100 km from the study hospital
(median distance=80 km, range; 2–375 km). Most parti-
cipants had stage III (45%) or IV (21%) disease at diag-
nosis. Squamous cell carcinoma (75%) was the
predominant histological subtype of cancer identiﬁed
(table 2).
Patient-related factors and cancer stage at diagnosis
Participants’ sociodemographics
In bivariate analyses, participants with secondary and ter-
tiary education were less likely to be diagnosed with
advanced stage cancer compared to those who had not
attained formal education (crude OR=0.16 (95% CI 0.03
to 0.87). After adjusting for age, marital status and edu-
cational attainment, the odds of advanced stage cancer
among patients with 5–9 children was 0.27 (95% CI 0.08
to 0.96) times the odds of advanced cancer among
women with less than four children (table 3).
Initial symptom attribution
Most participants (90.3%) did not attribute their initial
symptoms to cervical cancer (table 4). After controlling
for age, marital status, educational attainment and
number of biological children, the OR of advanced
stage cervical cancer among patients who perceived
their symptoms as due to a serious illness or cancer was
0.43 times (95% CI 0.20 to 0.96) the OR of those who
perceived their symptoms as not due to a serious illness/
cancer (table 4).
Socioeconomic factors
After adjusting for the patients’ sociodemographics,
patients who reported lack of money as reason for non-
prompt health seeking were more likely to be diagnosed
at advanced stage cervical cancer while those who per-
ceived their symptoms as serious or due to cancer were
less likely to be diagnosed at advanced stage cancer. The
odds of advanced stage cancer among patients who self-
reported ﬁnancial difﬁculty are 5.7 times (95% CI 1.58
to 20.64) the odds of advanced cancer among the
patients who did not report ﬁnancial difﬁculty as a
reason for non-prompt health seeking (table 4).
Health system factors and cancer stage at diagnosis
About one in three patients with cervical cancer resided
>100 km from the study hospital (table 2). About a
quarter of the participants attended care 3–5 times
before referral (table 4). After controlling for patients’
demographics, the odds of advanced stage cervical
cancer among patients who were assigned pre-referral
diagnoses of cancer are 13.04 times (95% CI 3.59 to
47.30) the odds among those assigned non-cancer-
related diagnoses (table 4).
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Total time to diagnosis at study hospital (appraisal and
help-seeking intervals)
More than half (55%) of the participants presented at
the study hospital after 3 months or more from reported
date of onset of symptoms. Of these, 71.8% (51/71) had
advanced stage cervical cancer. Although not statistically
signiﬁcant, participants who took a longer time to pres-
entation tended to be diagnosed at an advanced stage
(table 4).
DISCUSSION
The study provides early insights about the range of psy-
chosocial and healthcare factors that are likely to be asso-
ciated with prolonged intervals and advanced stage at
diagnosis of cervical cancer in Uganda, and should
motivate the conduct of multisite studies to establish
more independent predictors of advanced stage cervical
cancer at diagnoses in LMICs. The ﬁndings suggest that
several patient characteristics (including age, educational
attainment, marital status and number of biological chil-
dren) and primary healthcare factors may inﬂuence
diagnostic intervals, and the stage of cervical cancer at
diagnosis. More than half of patients with cervical cancer
attending care at St. Mary’s hospital, Lacor during the
study period were diagnosed at an advanced stage.
The odds of advanced stage cancer were higher
among older women. Similarly, in Sudan, older age was
found to be an independent predictor of advanced stage
cervical cancer.16 In other LMICs, older women were
also found to have long help-seeking intervals for their
symptoms and were more likely to be diagnosed with
advanced stage cervical cancer.3 16–18 Older women are
likely to be postmenopausal and may be less keen to
seek care promptly for gynaecological symptoms. We
also found that women with secondary and tertiary edu-
cation were less likely to be diagnosed with advanced
stage cancer. Similarly, higher level of education was
found to be associated with earlier stage at diagnosis in
Nepal.1 There is evidence that the association between
low education level (or other markers of low socio-
economic status) and advanced stage cervical cancer
seem to be mediated by early onset of sexual activity
among women with low education.19
The odds of advanced stage cervical cancer among
widowed and divorced women were 1.8–2.3 times the
odds among married women. Similar ﬁndings were
reported in studies conducted in North Africa and
India.18 20 In the North African study, unmarried
women were found to be ﬁve times as likely to be diag-
nosed at an advanced stage compared to married
women.20 Unmarried women in the USA were also more
likely to be diagnosed with advanced stage cervical
cancer.21 Perhaps married women enjoy emotional and
ﬁnancial support from their spouses and therefore tend
to seek help promptly. Evidence indicating a supportive
role of husbands is alluded to by ﬁndings from Nepal,
where women who discussed their symptoms with
friends were more likely to be diagnosed in advanced
stage compared to those who discussed symptoms with
their husbands.1 Married women are perhaps less likely
Table 2 Demographic characteristics of patients and
disease characteristics
Characteristics
Number
(N=149) Percentage
Age group (years)
18–29 7 4.7
30–44 52 34.6
45–59 63 42.7
≥60 25 16.7
Missing 2 1.3
Mean age (±SD) years 48.4±12.6
Median age 49.0 (23–80)
Marital status
Married 84 56.4
Divorced 21 14.1
Widowed 44 29.5
Mean age at marriage
(years)
17.7±2.3
Median age 18 (13–27)
years
Education attainment
No formal education 67 45.0
Primary education 72 48.3
Secondary education 7 4.7
Tertiary education 2 1.3
Missing 1 0.7
Occupation
Housewife/peasant 132 88.6
Petty trader 10 6.7
Formally employed 4 2.7
Missing 3 2.0
Number of biological children
No child 2 1.3
1–4 28 18.7
5–10 108 72.0
11–15 10 6.7
Missing 1 0.7
Stage of cancer at diagnosis (FIGO)
Stage I 17 11.4
Stage II 29 19.5
Stage III 67 45.0
Stage IV 31 20.8
Missing 5 3.3
Histological subtypes
Squamous cell carcinoma 111 74.5
Adenocarcinoma 12 8.1
Anaplastic type 1 0.7
Missing 25 16.7
Estimated distance from home to study hospital
(Kilometres)
Less than 40 41 27.5
40–80 35 23.5
81–100 13 8.7
101–375 58 38.9
Missing 2 1.3
Median (range) 80 (2–375)
FIGO, International Federation of Gynaecology and Obstetrics.
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to ignore vaginal bleeding and pain because of asso-
ciated discomfort during sexual intercourse. If married
women have a higher frequency of intercourse, this may
also lead to a higher symptom burden if the disease is
present (eg, painful intercourse, post-coital bleeding),
therefore prompting earlier presentation.
Patients’ attribution of their symptoms and percep-
tions of their likely causes may inﬂuence time to help
seeking and diagnosis of cancer. We found that patients
who initially attributed their symptoms to sexually trans-
mitted diseases (STDs) and/or who never perceived
their symptoms as due to a serious illness or cancer,
were more likely to be diagnosed with advanced stage
cervical cancer compared to those who did not attribute
their symptoms to STDs and those who perceived their
symptoms as due to a serious illness or cancer. For
instance, when adjusted for effect of age, marital status,
educational attainment and number of biological chil-
dren, women who perceived their symptoms to be due
to a serious disease or cancer were statistically signiﬁ-
cantly less likely to be diagnosed at an advanced stage
(0.43: 95% CI 0.20 to 0.96) compared to those who did
not perceive their symptoms as due to a serious illness
or cancer. In a recent systematic review, it was shown that
non-recognition of symptom seriousness was related with
advanced stage cancer.22 Similarly, patients with oral
cancers did not initially take their symptoms seriously
and attributed such symptoms to common oral condi-
tions for which they responded by self-medication.23
Apart from the sociodemographic characteristics of
women, advanced stage at diagnosis may relate to other
factors that prolong the help-seeking intervals, for
example, long distances from diagnostic facilities, lack of
money for transport and medical bills, and/or non-
recognition of cancer symptoms by primary healthcare
professionals. Non-prompt help seeking because of self-
reported lack of money was associated with advanced
stage at diagnosis. On adjusting for age, marital status,
educational attainment and number of biological chil-
dren, women who reported lack of money as reason for
non-prompt help seeking were 5.7 times more likely to
be diagnosed with advanced stage cancer compared to
those who did not report lack of money as reasons for
non-prompt help seeking. Similarly, ﬁnancial constraint
was reported as a main reason for not promptly seeking
help in India even among patients who suspected
cancer.24
Delayed recognition and/or referral by primary
healthcare clinicians can nonetheless lead to advanced
cancer stage at diagnosis in the referral facilities. In this
study, while about half of the patients with cancer
received pre-referral diagnoses of cancer at primary
healthcare facilities, their primary healthcare profes-
sionals did not recognise symptoms and/or suspect
cancer in the patients with early stage cancers and
referred symptomatic patients with other diagnoses not
related to cancer. On adjusting for age, marital status,
educational attainment and number of biological chil-
dren, the odds of advanced cervical cancer among
patients assigned pre-referral diagnoses of cancer were
13 times the odds of advanced cancer among women
who were assigned other pre-referral diagnoses not
related to cancer. In Nepal, healthcare professionals in
lower level units made other diagnoses in 90% of the
Table 3 Adjusted OR for patients’ sociodemographic characteristics and stage at diagnosis
Cancer stage at
diagnosis
Early stage
Advance
stage
Patient demographic characteristics
Population
responding
Number
(%)
Number
(%)
Crude OR (COR)
(95% CI)
Adjusted OR
(AOR) (95%CI)*
Age group (years)
<30 6 (4.2) 3 (6.5) 3 (3.1) 1.00 1.00
30–59 111 (78.2) 40 (87.0) 71 (74.0) 1.78 (0.34 to 9.21) 2.62 (0.33 to 21.1)
≥60 25 (17.6) 3 (6.5) 22 (22.9) 7.33 (0.99 to 54.4) 9.82 (0.81 to 118.9)
Marital status
Married 81 (56.3) 31 (67.4) 50 (51.0) 1.00 1.00
Divorced 19 (13.2) 4 (8.7) 15 (15.3) 2.32 (0.71 to 7.65) 1.81 (0.49 to 6.72)
Widowed 44 (30.5) 11 (23.9) 33 (33.7) 1.86 (0.82 to 4.21) 1.26 (0.51 to 3.12)
Education attainment
No formal education 67 (48.2) 22 (47.8) 45 (46.4) 1.00 1.00
Primary education 68 (47.6) 18 (39.1) 50 (51.6) 1.36 (0.65 to 2.85) 1.44 (0.62 to 3.34)
Secondary and/or tertiary education 8 (5.6) 6 (13.0) 2 (2.0) 0.16 (0.03 to 0.87) 0.18 (0.03 to 1.22)
Number of biological children
0–4 28 (19.6) 5 (11.1) 23 (23.5) 1.00 1.00
5–9 89 (62.2) 34 (75.6) 55 (56.1) 0.35 (0.12 to 1.01) 0.27 (0.08 to 0.96)
10–15 26 (18.2) 6 (13.3) 20 (20.4) 0.72 (0.19 to 2.74) 0.45 (0.1 to 2.09)
Bold typeface indicates statistically significant values.
*Adjusted for age, marital status, education attainment and number of biological children.
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initial pre-referral consultations by patients with cervical
cancer symptoms and delayed referral to cancer diagnos-
tic centres.1 In a qualitative study in South Africa,
primary healthcare professionals were also blamed for
prolonged diagnostic intervals in symptomatic women.6
Lack of speciﬁcity of cervical cancer symptoms and inad-
equate facilities to aid diagnosis of cervical cancer by
healthcare professionals may account for the misinter-
pretations of cervical cancer symptoms and subsequent
diagnosis of non-cervical cancer conditions.25
Strengths and limitations
Strengths to this study include the use of a theoretical
model (ﬁgure 1) to evaluate factors that may inﬂuence
symptoms appraisal and help-seeking intervals.
Furthermore, participants were prospectively recruited,
minimising methodological concerns associated with
retrospective studies. Finally, diagnosis of cervical cancer
was conﬁrmed by tissue histology and examination fol-
lowing EUAs and this obviates possibilities of diagnostic
misclassiﬁcations.
The ﬁndings are subject to potential recall or social
desirability biases inherent in patient interview studies.
Most patients presented at the study hospital long after
onset of symptoms and could have had difﬁculty in
recall of some events. We had no independent way to
ascertain dates of ﬁrst help seeking in primary care units
since records of the lower level health units were not
accessible to us for independent veriﬁcation. However,
even when primary care records of patients subsequently
diagnosed with cancer were used, there was still a poten-
tial for inaccurate measurement of patient interval in
particular and, ideally, both primary care and patient-
reported data needed to be studied (which was impos-
sible in our setting).26 We facilitated recall accuracy by
use of calendar landmark techniques, and allowed time
between disclosure of cancer diagnosis and question-
naire administration.27 In addition, other diseases that
present with symptoms similar to what have eventually
been diagnosed as cervical cancer could also affect
determining the exact time when the actual symptoms
of cervical cancer could have started. Measurement of
Table 4 Primary care factors and stage at diagnosis
Cancer stage at diagnosis
Early stage
Advanced
stage
Primary care factors
Population
responding
Number
(%)
Number
(%)
Crude OR (COR)
(95% CI)
Adjusted OR*
(95% CI)
Symptoms were initially attributed by the patient to
Sexually transmitted diseases
No 121 (84.0) 41 (89.1) 80 (81.6) 1.00 1.00
Yes 23 (16.0) 5 (10.9) 18 (18.4) 1.85 (0.64 to 5.32) 3.24 (0.93 to 11.32)
Cancer
No 130 (90.3) 39 (84.8) 91 (92.9) 1.00 1.00
Yes 14 (9.7) 7 (15.2) 7 (7.1) 0.43 (0.14 to 1.30) 0.30 (0.08 to 1.16)
Pre-referral diagnoses by primary healthcare professional
Non-cancer related 21 (15.4) 16 (37.2) 5 (5.4) 1.00 1.00
Cancer diagnosis 75 (55.2) 16 (37.2) 59 (63.4) 11.8 (3.75 to 37.12) 13.04 (3.59 to 47.30)
Not told diagnosis 40 (29.4) 11 (25.6) 29 (31.2) 8.44 (2.10 to 28.6) 8.35 (2.13 to 32.79)
Number of pre-referral visits at primary healthcare facilities
Once 54 (48.2) 17 (43.6) 37 (50.7) 1.00 1.00
Twice 29 (25.9) 13 (33.3) 16 (21.9) 0.57 (0.22 to 1.43) 0.68 (0.24 to 1.94)
Three to five or more 29 (25.9) 9 (23.1) 20 (27.4) 1.02 (0.39 to 2.70) 0.87 (0.28 to 2.65)
Health-seeking interval (months)
<3 59 (45.4) 23 (53.5) 36 (41.4) 1.00 1.00
3–6 51 (39.2) 15 (34.9) 36 (41.4) 1.53 (0.69 to 3.41) 1.55 (0.62 to 3.86)
7–24 20 (15.4) 5 (11.6) 15 (17.2) 1.92 (0.61 to 5.99) 1.93 (0.52 to 7.23)
Reasons for lack of promptness in seeking care
Lack of money
No 108 (75.0) 43 (93.5) 65 (66.3) 1.00 1.00
Yes 36 (25.0) 3 (6.5) 33 (33.7) 7.28 (2.10 to 25.22) 5.70 (1.58 to 20.64)
Still using other treatments
No 84 (58.3) 23 (50.0) 61 (62.2) 1.00 1.00
Yes 60 (41.7) 23 (50.0) 37 (37.8) 0.61 (0.30 to 1.23) 0.66 (0.30 to 1.43)
Perceived illness as not serious or cancer
No 86 (59.7) 20 (43.5) 66 (67.4) 1.00 1.00
Yes 58 (40.3) 26 (56.5) 32 (32.6) 0.37 (0.18 to 0.77) 0.43 (0.20 to 0.96)
Bold typeface indicates statistically significant values.
*OR adjusted for patients’ sociodemographic characteristics in table 3.
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time of onset of symptoms and time intervals during
help seeking is known to be challenging.25 Second, this
was a hospital-based study involving a selected popula-
tion of women who had reached the hospital. The
characteristics of women who may have cervical cancer
but who have not reached the study hospital remain
unknown. Generalisation of these ﬁndings needs to take
these issues into consideration.
Implications of findings
This study provides an initial experience with the
conduct of such studies, proving both their feasibility
and the need for larger and multisite data collection.
Acknowledging power limitations, the ﬁndings suggest
that advanced stage at diagnosis and long help-seeking
intervals could be owing to patients’ misattributions of
their symptoms, primary healthcare providers treating
cervical cancer symptoms for different common condi-
tions, and a lack of prompt healthcare seeking mainly
because of lack of money for transport and medical
bills. These ﬁndings may have far-reaching implications
for clinical care, public health and policy. First, interven-
tions to increase symptoms’ recognition need to target
women as well as clinicians, and may take the form of
public awareness campaigns and continuous professional
development (CPD) for healthcare professionals,
respectively. Women who are older, with no or low levels
of formal education and widowed/divorced may consti-
tute a special group for interventions to promote
prompt help seeking and diagnosis of cervical cancer.
Second, to reduce the proportion of advanced stage cer-
vical cancer at diagnoses, policymakers in LMICs ought
to prioritise cervical cancer control programmes that
include establishment of population-based cervical
screening and prompt treatment of preinvasive and
early invasive cervical lesions. However, in the meantime,
policies on cervical cancer, early detection of preinvasive
and early invasive lesions through scheduled CPDs to
healthcare professionals, and public awareness cam-
paigns on cervical cancer for the public can be adopted,
as they have been shown to be feasible and affordable
and can lead to increased survival for those with cervical
cancer.28
Future studies in Uganda and other LMICs seeking to
detect and explain independent predictors of advanced
stage cervical cancer may need to include interviews of
primary healthcare providers in lower level health facil-
ities in order to provide corroborating evidence and
establish reasons for long patient intervals in patients
with symptoms of cancer.
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